Spark Therapeutics (ONCE) Misses Q1 EPS by 11c

Spark Therapeutics (NASDAQ: ONCE) reported Q1 EPS of ($0.95), $0.11 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.48 million.

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22